These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9667539)

  • 1. Use of insulin lispro in the outpatient management of ketonuria.
    Travaglini MT; Garg SK; Chase HP
    Arch Pediatr Adolesc Med; 1998 Jul; 152(7):672-5. PubMed ID: 9667539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM.
    Attia N; Jones TW; Holcombe J; Tamborlane WV
    Diabetes Care; 1998 May; 21(5):817-21. PubMed ID: 9589247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postprandial glycaemia after regular and lispro insulin in children and adolescents with diabetes.
    Rami B; Schober E
    Eur J Pediatr; 1997 Nov; 156(11):838-40. PubMed ID: 9392394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous use of a fast-acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis.
    Della Manna T; Steinmetz L; Campos PR; Farhat SC; Schvartsman C; Kuperman H; Setian N; Damiani D
    Diabetes Care; 2005 Aug; 28(8):1856-61. PubMed ID: 16043723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin lispro lowers postprandial glucose in prepubertal children with diabetes.
    Deeb LC; Holcombe JH; Brunelle R; Zalani S; Brink S; Jenner M; Kitson H; Perlman K; Spencer M
    Pediatrics; 2001 Nov; 108(5):1175-9. PubMed ID: 11694699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin lispro: a review of its pharmacological properties and therapeutic use in the management of diabetes mellitus.
    Wilde MI; McTavish D
    Drugs; 1997 Oct; 54(4):597-614. PubMed ID: 9339963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy.
    Durnwald CP; Landon MB
    J Matern Fetal Neonatal Med; 2008 May; 21(5):309-13. PubMed ID: 18446657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin lispro: a review of its use in the management of diabetes mellitus.
    Simpson D; McCormack PL; Keating GM; Lyseng-Williamson KA
    Drugs; 2007; 67(3):407-34. PubMed ID: 17335298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of pregnancy in type 1 diabetic patients treated with insulin lispro or regular insulin: an Italian experience.
    Lapolla A; Dalfrà MG; Spezia R; Anichini R; Bonomo M; Bruttomesso D; Di Cianni G; Franzetti I; Galluzzo A; Mello G; Menato G; Napoli A; Noacco G; Parretti E; Santini C; Scaldaferri E; Scaldaferri L; Songini M; Tonutti L; Torlone E; Gentilella R; Rossi A; Valle D
    Acta Diabetol; 2008 Mar; 45(1):61-6. PubMed ID: 18227964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-prandial insulin lispro vs. human regular insulin in prepubertal children with Type 1 diabetes mellitus.
    Tupola S; Komulainen J; Jääskeläinen J; Sipilä I
    Diabet Med; 2001 Aug; 18(8):654-8. PubMed ID: 11553203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of retinopathy during pregnancy in type 1 diabetic women treated with insulin lispro.
    Loukovaara S; Immonen I; Teramo KA; Kaaja R
    Diabetes Care; 2003 Apr; 26(4):1193-8. PubMed ID: 12663596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes.
    Brunelle BL; Llewelyn J; Anderson JH; Gale EA; Koivisto VA
    Diabetes Care; 1998 Oct; 21(10):1726-31. PubMed ID: 9773738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of insulin lispro: pooled data from clinical trials.
    Glazer NB; Zalani S; Anderson JH; Bastyr EJ
    Am J Health Syst Pharm; 1999 Mar; 56(6):542-7. PubMed ID: 10192689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of insulin allergy in a 1-year-old infant with neonatal diabetes by lispro and glargine insulin.
    Kara C; Kutlu AO; Evliyaoglu O; Bilgili H; Yildirim N
    Diabetes Care; 2005 Apr; 28(4):983-4. PubMed ID: 15793215
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.
    Burge MR; Waters DL; Holcombe JH; Schade DS
    J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog).
    Masson EA; Patmore JE; Brash PD; Baxter M; Caldwell G; Gallen IW; Price PA; Vice PA; Walker JD; Lindow SW
    Diabet Med; 2003 Jan; 20(1):46-50. PubMed ID: 12519319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus.
    Chapman TM; Noble S; Goa KL
    Drugs; 2002; 62(13):1945-81. PubMed ID: 12215068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy. The UK Trial Group.
    Gale EA
    Diabet Med; 2000 Mar; 17(3):209-14. PubMed ID: 10784225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of type 1 diabetes with insulin lispro during Ramadan.
    Kadiri A; Al-Nakhi A; El-Ghazali S; Jabbar A; Al Arouj M; Akram J; Wyatt J; Assem A; Ristic S
    Diabetes Metab; 2001 Sep; 27(4 Pt 1):482-6. PubMed ID: 11547222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of lispro insulin and quality of life in adolescents on intensive therapy.
    Grey M; Boland EA; Tamborlane WV
    Diabetes Educ; 1999; 25(6):934-41. PubMed ID: 10711075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.